Using Convolutional Neural Networks for the Classification of Suboptimal Chest Radiographs.
Authors
Affiliations (2)
Affiliations (2)
- Department of Medical Imaging and Radiation Sciences, Monash University, Clayton, Victoria, Australia.
- Monash Imaging, Monash Health, Clayton, Victoria, Australia.
Abstract
Chest X-rays (CXR) rank among the most conducted X-ray examinations. They often require repeat imaging due to inadequate quality, leading to increased radiation exposure and delays in patient care and diagnosis. This research assesses the efficacy of DenseNet121 and YOLOv8 neural networks in detecting suboptimal CXRs, which may minimise delays and enhance patient outcomes. The study included 3587 patients with a median age of 67 (0-102). It utilised an initial dataset comprising 10,000 CXRs randomly divided into a training subset (4000 optimal and 4000 suboptimal) and a validation subset (400 optimal and 400 suboptimal). The test subset (25 optimal and 25 suboptimal) was curated from the remaining images to provide adequate variation. Neural networks DenseNet121 and YOLOv8 were chosen due to their capabilities in image classification. DenseNet121 is a robust, well-tested model in the medical industry with high accuracy in object recognition. YOLOv8 is a cutting-edge commercial model targeted at all industries. Their performance was assessed via the area under the receiver operating curve (AUROC) and compared to radiologist classification, utilising the chi-squared test. DenseNet121 attained an AUROC of 0.97, while YOLOv8 recorded a score of 0.95, indicating a strong capability in differentiating between optimal and suboptimal CXRs. The alignment between radiologists and models exhibited variability, partly due to the lack of clinical indications. However, the performance was not statistically significant. Both AI models effectively classified chest X-ray quality, demonstrating the potential for providing radiographers with feedback to improve image quality. Notably, this was the first study to include both PA and lateral CXRs as well as paediatric cases and the first to evaluate YOLOv8 for this application.